VCI Global to distribute AI-based 'Socializer Messenger' for Cogia » 07:31 VCIG Q- Who is Cogia Q- Who is VCI Global Q- What is an AI " Socializer Messenger "
Damn-- too far gone for a gummy> VCI Global Limited (VCIG) NasdaqCM - NasdaqCM Real Time Price. 2.8300+0.4100 (+16.94%)<----- At close: June 16 04:00PM EDT 3.6400 +0.81 (+28.62%)<----------- Pre-Market: 07:34AM EDT
-GUMMY- Lilium N.V. (LILM) NasdaqGS - NasdaqGS Real Time Price. 1.2700-0.0800 (-5.93%) At close: June 16 04:00PM EDT 1.4200 +0.15 (+11.81%)<------------- Pre-Market: 07:39AM EDT
IT'S HAPPENING..... Lilium signs agreement with Heli-Eastern for the purchase of Lilium Jets and the development of premium eVTOL services in China Sun, June 18, 2023 at 6:01 PM EDT Lilium GmbH Lilium signs agreement with Heli-Eastern for the purchase of Lilium Jets and the development of premium eVTOL services in China Lilium signs agreement with Heli-Eastern for the purchase of Lilium Jets and the development of premium eVTOL services in China • The two companies will jointly develop eVTOL services across the Guangdong-Hong Kong-Macao Greater Bay Area • Heli-Eastern intends to purchase 100 Lilium Jets • Heli-Eastern will operate the Lilium Jet fleet in the region and provide maintenance and crewing services Lilium signs agreement with Heli-Eastern for the purchase of Lilium Jets and the development of premium eVTOL services in China
-GUMMY- FSD Pharma Inc. (HUGE) NasdaqCM - NasdaqCM Real Time Price. 1.1900+0.0300 (+2.59%) At close: June 16 04:00PM EDT 1.2700 +0.08 (+6.72%)<--------------- Pre-Market: 07:32AM EDT
About FSD Pharma FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, a proprietary ultra-micronized PEA formulation, for the treatment of inflammatory diseases. Lucid Psychss Inc., a wholly owned subsidiary, is focused on the research and development of its lead compounds, Lucid-Psych and Lucid-MS. Lucid-Psych is a molecular compound identified for the potential treatment of mental health disorders, and expanding this category, the Company is investigating other products addressing acute medical needs due to the abuse of drugs such as alcohol. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders.
This is abit weird Cummins spun this co out as an IPO but retained 80%? Nothing went to the co in the IPO-- No $'s ?? Atmus Filtration Technologies Announces Closing of Initial Public Offering May 30, 2023 NASHVILLE, Tenn., May 30, 2023--(BUSINESS WIRE)--Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU), a global leader in the filtration industry, today announced the closing of its initial public offering ("IPO") of 16,243,070 shares of its common stock at a price to the public of $19.50 per share, including the underwriters’ full exercise of their option to purchase 2,118,661 additional shares. Shares of Atmus’ common stock began trading on the New York Stock Exchange under the symbol "ATMU" on May 26, 2023. The shares were sold by Cummins through a debt-for-equity exchange. As of the closing of the IPO, Cummins Inc. (Cummins; NYSE: CMI) owns approximately 80.5% of the total outstanding shares of Atmus common stock. Cummins has publicly stated its intention to make a tax-free split-off, pursuant to which Cummins will offer its stockholders the option to exchange their shares of Cummins common stock for shares of Atmus common stock in an exchange offer. Atmus did not sell any shares and did not receive any proceeds from the sale of shares in the offering. Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC acted as joint lead book-running managers and as representatives of the underwriters for the offering. Baird, BofA Securities, Wells Fargo Securities and HSBC also acted as joint book-running managers. PNC Capital Markets LLC, BTIG, ING, KeyBanc Capital Markets, Loop Capital Markets and Siebert Williams Shank acted as co-managers.